JPRN-UMIN000052322
Recruiting
未知
A multicenter, prospective, observational study for the control of delayed chemotherapy-induced nausea and vomiting for upper gastrointestinal cancer - A multicenter, prospective, observational study for the control of delayed chemotherapy-induced nausea and vomiting for upper gastrointestinal cancer
agoya University0 sites135 target enrollmentSeptember 27, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- agoya University
- Enrollment
- 135
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Cases in which emetic events are observed due to factors other than cancer chemotherapy (e.g., emetic events due to passage obstruction due to the underlying disease, emetic events due to brain metastases) 2\. Cases receiving continuous systemic administration of steroids exceeding 10 mg/day of prednisone equivalent. 3\. Cases in which the attending physician determines that enrollment in this study is inappropriate 4\. Cases with a history of hypersensitivity to the components of Fosnetupitant, Palonosetron, and Dexamethasone 5\. Pregnant women or women who may be pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A multicenter, prospective, observational study for the association serum pancreatic enzyme level and CT image findings in post-ERCP pancreatitisPost-ERCP pancreatitisJPRN-UMIN000024814Department of Gastroenterology, Kyoto Second Red Cross Hospital5,000
Completed
Not Applicable
A multicenter, prospective, observational study for the incidence and high risk factor of post-ERCP pancreatitisPost-ERCP pancreatitisJPRN-UMIN000024813Department of Gastroenterology, Kyoto Second Red Cross Hospital5,000
Completed
Not Applicable
Evaluation of facial skin parameters, scalp parameters, hair health and Ayurvedic Prakruti on healthy volunteers in winter and monsoon season.CTRI/2018/01/011147ITC Life Sciences and Technology Center
Recruiting
Not Applicable
Polatuzumab vedotin plus R-CHP therapy in patients with previously untreated diffuse large B-cell lymphomaDiffuse large B-cell lymphomDLBCLDLBCJPRN-jRCT1071220082Kato Koji500
Not yet recruiting
Not Applicable
A Clinical Study of the Efficacy and Safety of Corticosteroids for Cancer-induced Neuropathic Pain.Cancer painJPRN-UMIN000040584Tohoku University Graduate School of Medicine200